CClinicalTrials.gg
CompletedNCT06718777Updated Dec 5, 2024

Effect of Two Different Solutions on Wound Healing in Pressure Injury

An interventional study of 0.1% polyhexanide Care and 0.9 % NaCl Care in Pressure Injuries, Wound Care and Wound Cleansing, sponsored by Mensure Turan. Completed at 2 sites in Turkey. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2024-12-05.

Sponsored by Mensure Turan · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 1 year 3 months after the study started (first participant enrolled Aug 2023, registered Nov 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
63
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Pressure injuries are a condition that reduces patients' quality of life, increases hospitalization time and healthcare costs. When accompanied by infection and complications, mortality increases. The primary goal in pressure injuries is to prevent their occurrence, but once the injury has occurred, it is to provide effective and appropriate care. It is known that 0.9% sodium chloride (NaCl) is used routinely in pressure ulcer care. In addition, if the effectiveness of 0.1% polyhexanide in pressure ulcer care is demonstrated, it may provide data for its use in wound care. For this purpose, the study was completed as a randomized controlled trial with 32 individuals in the 0.1% polyhexanide group and 31 individuals in the 0.9% NaCl group, totaling 63 individuals.

Read the detailed description

The European Pressure Ulcer Advisory Panel (EPUAP) and the National Pressure Ulcer Advisory Panel (NPUAP) defined pressure injury (PI) as "Local skin and/or subcutaneous tissue damage caused by pressure alone, or by a combination of pressure and shear, most often occurring over bony prominences". It has been stated that the prevalence of pressure ulcers varies between 0-72.5%, and that it is a condition that reduces the quality of life of patients, increases the length of hospital stay and health care costs. In particular, the accompanying infection and complications of PI cause increased mortality. The primary purpose of PIs is to prevent their occurrence and after the injury occurs, it is necessary to provide care with effective and appropriate methods. The determined method should have the feature that can contribute to wound healing. There are many products and methods with appropriate features that can be used in PIs. In addition to the wet-dry gauze dressing used in wound care from past to present, different care solutions are also used. 0.9% NaCl solutions are frequently used in wound care. Since 0.1% polyhexanide solution is also an effective antiseptic, we thought that its use in PI care would contribute to treatment management by determining its effect on wound healing.

02

Conditions studied

  • Pressure Injuries
  • Wound Care
  • Wound Cleansing

Keywords

  • pressure injury
  • %0.1 poliheksanit solution
  • %0.9 sodium chloride
03

In context

Pressure Ulcer

518 studies on the registry are indexed under Pressure Ulcer; 117 are open to participants now.

This study's enrollment of 63 is close to the median of 70 across 395 interventional studies indexed under Pressure Ulcer.

Browse Pressure Ulcer studies →

Lead sponsor

This is the only study on the registry with Mensure Turan as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients over the age of 18 who have developed pressure injuries
  • Patients who have received informed consent from themselves or their guardians

Exclusion criteria

Exclusion Criteria:

  • Patients with clotting problems
  • Patients using corticosteroids
  • Patients receiving additional medical treatment for wound care
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
63 participants (actual)

Study arms

  • Experimental
    0.1% polyhexanide

    0.1% polyhexanide solution was applied 3 times at 48-hour intervals for pressure ulcer care.

    Other: 0.1% polyhexanide Care

  • Experimental
    0.9% NaCl

    0.9% sodium chloride solution was applied three times at 48-hour intervals for pressure ulcer care.

    Other: 0.9 % NaCl Care

Interventions

  • Other0.1% polyhexanide Care

    After the patient was randomized for pressure ulcer care, data were recorded at the first follow-up before care and pressure ulcer care was performed with 0.1% polyhexanide solution. Then, 2 treatments were performed at 48-hour intervals and PUSH scores were recorded before each care. A total of three pressure ulcer care and four follow-ups were performed.

  • Other0.9 % NaCl Care

    After the patient was randomized for pressure ulcer care, data were recorded at the first follow-up before care and pressure ulcer care was performed with 0.9% sodium chloride. Then, 2 care sessions were performed at 48-hour intervals and PUSH scores were recorded before each care. A total of three pressure ulcer care sessions and four follow-ups were performed.

06

What researchers measure

Primary outcomes

  1. PUSH score

    This scale, developed by NPUAP to evaluate the healing process of pressure injuries, was used in the study to evaluate the healing status of pressure injuries in patients receiving pressure injury care. The pressure injury healing status was monitored with the evaluation criteria in the scale. The lowest score to be received from PUSH is 0, and the highest score is 17. A decrease in the score indicates that the pressure injury has healed.

    Time frame: From 0th hour to 144th hour

Secondary outcomes

  1. NPUAP Pressure Sore Classification System

    Staging of pressure ulcers is important to assess the stage of the wound after it has formed to determine effective treatment methods. Staging indicates the severity of the pressure ulcer, its depth, the extent of skin affected, and the extent of tissue damage. The latest update was published by the NPUAP and EPUAP in 2009 as six stages.

    Time frame: 0th hour

07

Study locations

2 sites
  • Gazi Yaşargil Training and Research Hospital
    Diyarbakır, 21000, Turkey
  • Gazi Yaşargil Training and Research Hospital
    Diyarbakır, Turkey
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06718777
Lead sponsor
Mensure Turan
Responsible party
Mensure Turan (Asistant Professor, Şırnak Üniversitesi) — Sponsor-investigator
First posted
Dec 5, 2024
Start date
Aug 1, 2023
Primary completion
Jan 1, 2024
Completion
Aug 1, 2024
Last update
Dec 5, 2024

Study contacts

Mensure Turan, PhD
principal investigator · Şırnak Üniversitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion